List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 325 studies with search of:   Bulgaria
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Prospective Evaluation of Proteinuria and Renal Function in Non-Diabetic Patients With Progressive Renal Disease
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
2 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
3 Completed Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
Condition: NSCLC
Intervention: Drug: Gefitinib
4 Completed A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: GLP-1;   Drug: GLP-1;   Drug: GLP-1;   Drug: GLP-1;   Drug: GLP-1;   Drug: Placebo
5 Recruiting A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Conditions: Tumor;   Pain
Interventions: Drug: CG5503 ER;   Drug: Placebo to match CG5503;   Drug: Morphine Sulphate CR;   Drug: Placebo to match Morphine Sulphate CR
6 Recruiting Phase 3 Study to Evaluate Efficacy and Safety of Oxcarbazepine Extended-Release in Subjects With Refractory Partial Seizures Due to Epilepsy When Used With up to 2 Other Antiepileptic Drugs.
Condition: Epilepsy
Interventions: Drug: Placebo;   Drug: Oxcarbazepine Extended Release;   Drug: Oxcarbazepine Extended Release
7 Not yet recruiting The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Conditions: Atherosclerosis;   Cardiovascular Disease;   Coronary Heart Disease;   CV Risk
Interventions: Drug: Darapladib;   Drug: Placebo
8 Completed Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes
Intervention: Drug: Insulin sensitizer
9 Recruiting Study of LJP 394 in Lupus Patients With History of Renal Disease
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: abetimus sodium (LJP 394) and/or placebo solution;   Drug: abetimus sodium (LJP 394);   Drug: Phosphate-buffered saline
10 Completed An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
Conditions: Major Depressive Disorder;   Psychotic Disorders
Intervention: Drug: Mifepristone
11 Recruiting Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia
Condition: Bacterial Pneumonia
Interventions: Drug: ceftaroline;   Drug: ceftriaxone
12 Active, not recruiting "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
Condition: Prostate Cancer
Intervention: Drug: Dutasteride
13 Not yet recruiting FondaparinUx Trial With UFH During Revascularization in Acute Coronary Syndromes
Conditions: Non ST Segment Elevation Myocardial Infarction;   Unstable Angina;   Acute Coronary Syndrome
Intervention: Drug: Unfractioned heparin
14 Active, not recruiting A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: bevacizumab;   Drug: placebo;   Drug: erlotinib HCl
15 Completed Crestor Versus Placebo in Subjects With Heart Failure
Condition: Heart Failure
Intervention: Drug: rosuvastatin
16 Completed Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: AZD3480;   Drug: Donepezil
17 Completed Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension
Condition: Hypertension
Intervention: Drug: Daglutril
18 Active, not recruiting Randomized, Controlled, Double-Blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients
Conditions: Anemia;   Chronic Renal Insufficiency
Interventions: Drug: HX575 recombinant human erythropoietin alfa;   Drug: ERYPO
19 Active, not recruiting Efficacy and Safety Study of TAK-491 Compared to Ramipril for Treating Essential Hypertension
Condition: Essential Hypertension
Interventions: Drug: TAK-491;   Drug: TAK-491;   Drug: Ramipril
20 Active, not recruiting A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: CCX282-B

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services